没有数据	没有数据

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Compared effects of isoxicam and indomethacin on the urinary excretion of prostaglandins in degenerative articular diseases.J Sassard et al.Prostaglandins, leukotrienes, and essential fatty acids, 38(2), 107-111 (1989-11-01) A review of HPLC methods used for determining the presence of meloxicamBrezovska M, et al. Current Pharmaceutical Analysis, 9(1), 69-76 (2013) Controlled-release naproxen compared with isoxicam in patients with osteoarthritis.W Frankhof Current medical research and opinion, 11(1), 28-33 (1988-01-01) [The effect of estro-progesterones on the inflammatory episodes of hand arthroses. Apropos of a case].M Laroche et al.Revue du rhumatisme et des maladies osteo-articulaires, 56(10), 709-711 (1989-10-01) The effect of administration of phenytoin on the pharmacokinetics of isoxicam.G Caillé et al.Biopharmaceutics & drug disposition, 8(1), 57-61 (1987-01-01) [Severe toxic dermatitis caused by tenoxicam (Tilcotil). 3 cases].O Chosidow et al.Annales de dermatologie et de venereologie, 118(11), 903-904 (1991-01-01) Metabolic disposition of the non-steroidal anti-inflammatory agent isoxicam in man.T F Woolf et al.European journal of drug metabolism and pharmacokinetics, 17(1), 21-27 (1992-01-01) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.N Bellamy et al.The Journal of rheumatology, 15(12), 1833-1840 (1988-12-01) [Cytogenetic studies of human lymphocytes under the influence of oxicams].W Kullich et al.Zeitschrift fur Rheumatologie, 49(2), 77-81 (1990-03-01) In vitro metabolism of isoxicam by horseradish peroxidase.T F Woolf et al.Xenobiotica; the fate of foreign compounds in biological systems, 19(12), 1369-1377 (1989-12-01) In vivo metabolism of isoxicam in rats, dogs, and monkeys.T F Woolf et al.Drug metabolism and disposition: the biological fate of chemicals, 17(6), 662-668 (1989-11-01) Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.Renzo Cini et al.Journal of inorganic biochemistry, 101(8), 1140-1152 (2007-06-27) Comparative biochemical pharmacology of the oxicams.H Fenner Scandinavian journal of rheumatology. Supplement, 65, 97-101 (1987-01-01) Comparative biochemical pharmacology of the oxicams.H Fenner European journal of rheumatology and inflammation, 9(2), 3-7 (1987-01-01) Isoxicam.W W Downie et al.Clinics in rheumatic diseases, 10(2), 385-399 (1984-08-01) Evidence for isoxicam binding to site I as a primary site and to site II as a secondary site of human serum albumin.F Bree et al.Biochemical pharmacology, 38(5), 753-758 (1989-03-01) Solid-phase molecularly imprinted pre-concentration and spectrophotometric determination of isoxicam in pharmaceuticals and human serum.B Rezaei et al.Talanta, 78(2), 418-423 (2009-02-11) Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.Gabriella Tamasi et al.Journal of inorganic biochemistry, 102(10), 1862-1873 (2008-08-01) Pharmacokinetic disposition of isoxicam in hepatic cirrhosis.M Esquivel et al.Clinical and investigative medicine. Medecine clinique et experimentale, 10(5), 363-367 (1987-09-01) Liquid chromatography-tandem mass spectrometry method for the determination of meloxicam and its metabolite 5-carboxymeloxicam in human plasma.Hye Won Lee et al.Bioanalysis, 1(1), 63-70 (2009-04-01) Flow injection chemiluminescence determination of isoxicam based on diperiodatoargentate (III)-fluorescein system in a micellar mediumZhao F and Si H Journal of Luminescence, 135(1), 259-264 (2013) Effect of some new prostaglandin synthetase inhibitors on the endotoxin induced mortality and biochemical changes in experimental animals.M Tariq Research communications in chemical pathology and pharmacology, 60(1), 19-25 (1988-04-01) Determination of pKa values of tenoxicam from 1H NMR chemical shifts and of oxicams from electrophoretic mobilities (CZE) with the aid of programs SQUAD and HYPNMR.Damaris Rodríguez-Barrientos et al.Talanta, 80(2), 754-762 (2009-10-20) Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs).M Schmitt et al.Scandinavian journal of rheumatology. Supplement, 80, 86-89 (1989-01-01) [The binding of oxicam derivatives to human serum albumin].A Kinawi et al.Arzneimittel-Forschung, 38(8), 1089-1092 (1988-08-01) The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis.E M Grace et al.Current medical research and opinion, 10(9), 580-591 (1987-01-01) Oxicams: metabolic disposition in man and animals.T F Woolf et al.Drug metabolism reviews, 21(2), 255-276 (1989-01-01) Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.Clare E Buckley et al.Neuropharmacology, 59(3), 149-159 (2010-05-11)

备注